Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Share News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.25
Bid: 35.00
Ask: 35.50
Change: -0.50 (-1.40%)
Spread: 0.50 (1.429%)
Open: 35.75
High: 35.75
Low: 35.25
Prev. Close: 35.75
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Creo unveils product in APAC; Unilever hires director

Wed, 31st Jan 2024 18:15

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Unilever PLC - London-based maker of food & drink, cleaning, toiletry, and personal care products - Appoints Judith McKenna as an independent non-executive director. She will join the board on March 1. Says: "Judith has deep and extensive experience of the consumer goods and retail sector, having spent 27 years of her career at Walmart. She most recently served as President and CEO of Walmart International from 2018-2023, where she was responsible for all aspects of Walmart's footprint outside the US." Prior to leading Wal-Mart International, says McKenna served as executive vice president and chief operating officer for Wal-Mart US and was the chief financial officer for UK supermarket chain Asda for more than a decade.

----------

Leeds Group PLC - West Yorkshire, England-based textile manufacturing company - Further to announcement earlier this month that its shareholders voted in favour of a proposed USD657,000 disposal of its subsidiary Hemmers-Itex Textil Import Export GmBH to Nooteboom Bidco BV, says the sale is ongoing and yet to be formally completed. It remains optimistic that the proposed sale will complete "shortly" and that a further announcement will be made in "due course".

----------

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Announces continued progress on the phased market release of its Speedboat UltraSlim device, which has now been successfully used in the Asia Pacific region for the first time. Earlier this month, it had been been used successfully in Latin America for the first time. Since December, it has also been successfully used in the UK and the US. In Asia Pacific, says: "The device has been used to treat precancerous lesions in the colon, oesophagus and stomach as well as during procedures to surgically correct gastric and oesophageal abnormalities to help patients with swallowing and acid reflux disorders. In all cases these procedures help move patients from operating theatre procedures to endoscopic procedures with the inherent reduced impact on the patient and associated costs." Chief Executive Officer Craig Gulliford adds: "We're very pleased that Speedboat UltraSlim has now reached the Asia Pacific region, representing tremendous progress with the phased initial market release in a short period of time. The team have done a terrific job with the regional regulatory steps necessary to enable this limited market release programme and we are excited to extend the roll-out to reach all of our customers in the coming months. APAC represents the fourth continent where the device has now been used in clinic and along with Dr. Hon Chi Yip and Dr. Simon Chu, we have had fantastic feedback from all customers who have so far had access to the new technology."

----------

Synergia Energy Ltd - India and UK-focused gas production and carbon capture and storage project development company - Updates on Cambay production sharing contract farm-out in Gujarat state, India. Says it continues to hold meetings in India this week with the unnamed potential joint venture partner, particularly over finalising the farm out agreement and joint operating agreement. Says it and the prospective partner aim to execute these agreements in early next month.

----------

Chariot Ltd - Africa-focused transitional energy company - Says electricity trading platform Etana Energy (Pty) Ltd, in which Chariot has a 49% stake, signs "milestone" power purchase agreement with Growthpoint Properties Ltd to supply them with 195 gigawatt hours of renewable energy per year. Chariot says this represents 32% of Growthpoint's total current annual electricity consumption and Etana will wheel electricity to their commercial property buildings located in several jurisdictions in South Africa. Chariot says the agreement represents South Africa's "first multi-jurisdiction, multi-building, multi-source renewable energy wheeling arrangement". The supply will mainly consist of wind power, with components of solar and hydroelectricity. Through this agreement with Etana, Chariot says Growthpoint has secured the rights to purchase hydroelectricity generating roughly 30GWh per year by a 5MW hydroelectric power plant developed, owned and operated by Serengeti Energy, which will be wheeled by Etana. Chariot says the hydroelectric power plant has reached financial close and is currently under construction. Once in production, which is expected in the second quarter of 2025, Chariot says it will generate baseload power on a 24/7 basis.

----------

Oxford Metrics PLC - Oxford, England-based software provider - Ahead of its annual general meeting earlier, Chief Executive Officer Imogen Moorhouse says it entered the new financial year with "well over half of revenue expectations underpinned by orders in hand and a strong sales pipeline". CEO Moorhouse says: "The board is pleased to report that the solid start has continued with good early trading in the new financial year. The group continues to have strong visibility, which is now reflecting the normalisation of customer buying behaviour compared with the past years of disruption caused by the pandemic and supply chain challenges. Trading is in-line with expectations...The board looks forward to the year which is set to see further growth in existing markets whilst laying the foundations for future growth - which will be covered in more detail at our capital markets day in April." Says further information on trading will be provided when it announces its interim results for the six months ending March 31.

----------

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
24 Apr 2024 16:04

TRADING UPDATES: ActiveOps sales up; Sancus turnover jumps

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Mar 2024 14:06

Creo device used in 'groundbreaking' lung cancer procedure

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

Read more
1 Mar 2024 13:34

EARNINGS AND TRADING: Dar Global celebrates "outstanding" year

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
7 Feb 2024 11:49

Creo Medical FY revenues up double digits

(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.

Read more
7 Feb 2024 10:54

Creo Medical makes "considerable strides" toward 2025 break-even goal

(Alliance News) - Creo Medical Group PLC on Wednesday said that cost controls and new product sales had supported strong growth in 2023, as the company said it is on track to achieve cash flow break-even by 2025.

Read more
5 Feb 2024 12:11

IN BRIEF: Creo Medical partners with Khalifa University in Abu Dhabi

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Will collaborate with Khalifa University of Science & Technology in Abu Dhabi. Says partnership has an initial focus on healthcare challenges relevant to the population in the United Arab Emirates, as well as the wider Middle East and North Africa region. Chief Executive Officer Craig Gulliford says: "As part of our strategy, we are driven to exploit our IP either directly or in partnership with third-parties, as shown by our robotic assisted surgery collaborations. Khalifa University is a research-intensive organisation with a similar drive to develop and commercially exploit leading technologies, at scale and on a global basis. The combination of Creo's people, technology and IP with Khalifa University's teams, technologies, facilities and resources represents a great opportunity for both organisations to advance and commercialise incremental technology and products and enhance research profiles internationally."

Read more
10 Jan 2024 12:32

Creo Medical's Speedboat UlstraSlim device used in Latin America

(Alliance News) - Creo Medical Group PLC on Wednesday said its Speedboat UltraSlim device has been used successfully in Latin America for the first time.

Read more
15 Dec 2023 14:17

IN BRIEF: Creo Medical's SpeedBoat UltraSlim successfully used in US

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Says SpeedBoat UltraSlim device has been successfully used in the US across multiple clinical applications. SpeedBoat UltraSlim is third brand in its Speedboat family of devices alongside Speedboat Inject and offers a number of different features.This primarily includes the reduced size in comparison with the Speedboat Inject, Creo Medical said, making the device compatible with all endoscopes with a 2.8 millimetre working channel or larger.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Dec 2023 14:28

Creo launches 'Speedboat Ultraslim' with first UK procedure

(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.

Read more
1 Nov 2023 14:28

Creo Medical gets US FDA clearance for Speedboat UltraSlim

(Sharecast News) - Medical device company Creo Medical Group announced on Wednesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Speedboat UltraSlim device.

Read more
25 Oct 2023 13:44

Creo Medical accelerating EU launch of Speedboat UltraSlim

(Sharecast News) - Creo Medical Group announced the acceleration of its EU launch of the 'Speedboat UltraSlim' device by around 18 months on Wednesday.

Read more
25 Oct 2023 13:41

Creo Medical says EU launch of SpeedBoat UltraSlim device accelerated

(Alliance News) - Creo Medical Group PLC on Wednesday said the EU launch of its SpeedBoat UltraSlim device has been accelerated by around 18 months ahead of schedule.

Read more
12 Sep 2023 11:47

Creo Medical hails Speedboat Inject device as interim loss narrows

(Alliance News) - Creo Medical Group PLC on Tuesday reported a narrowed interim loss amid higher revenue.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.